Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC)
2.960
0.00 (0.00%)
Sep 3, 2026, 4:36 PM ICT
BKK:AMARC Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,203 | 1,092 | 538 | 575 | 1,168 | - | |
Market Cap Growth | -24.24% | 103.13% | -6.57% | -50.72% | - | - |
Enterprise Value | 1,083 | 923 | 474 | 520 | 1,380 | - |
Last Close Price | 2.96 | 2.45 | 1.14 | 1.15 | 2.23 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.73 | 6.89 | 13.47 | 59.66 | 80.44 | - |
Forward PE | 9.40 | 7.48 | 16.00 | 18.77 | 23.17 | - |
PS Ratio | 2.58 | 2.21 | 1.54 | 1.96 | 4.42 | - |
PB Ratio | 2.06 | 1.81 | 1.03 | 1.12 | 2.13 | - |
P/TBV Ratio | 2.14 | 1.89 | 1.08 | 1.17 | 2.22 | - |
P/FCF Ratio | 12.16 | 6.91 | 9.32 | - | 35.65 | - |
P/OCF Ratio | 8.32 | 5.26 | 6.75 | 12.68 | 21.82 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.32 | 1.87 | 1.36 | 1.77 | 5.22 | - |
EV/EBITDA Ratio | 6.57 | 4.75 | 6.25 | 25.43 | 25.89 | - |
EV/EBIT Ratio | 8.62 | 5.83 | 11.46 | 32.96 | 57.22 | - |
EV/FCF Ratio | 10.94 | 5.84 | 8.22 | - | 42.14 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.04 | 0.04 | 0.07 | 0.14 | 0.18 | 0.82 |
Debt / EBITDA Ratio | 0.15 | 0.11 | 0.47 | 1.32 | 1.67 | 2.78 |
Debt / FCF Ratio | 0.25 | 0.13 | 0.67 | - | 2.92 | 3.19 |
Net Debt / Equity Ratio | -0.21 | -0.28 | -0.14 | -0.11 | -0.24 | 0.80 |
Net Debt / EBITDA Ratio | -0.75 | -0.85 | -0.96 | -2.68 | -2.47 | 2.86 |
Net Debt / FCF Ratio | -1.22 | -1.05 | -1.26 | 4.36 | -4.03 | 3.10 |
Asset Turnover | 0.63 | 0.74 | 0.54 | 0.44 | 0.46 | 0.57 |
Inventory Turnover | 17.05 | 19.01 | 19.50 | 16.26 | 16.06 | 18.05 |
Quick Ratio | 2.29 | 4.50 | 2.57 | 2.80 | 4.17 | 0.59 |
Current Ratio | 2.49 | 4.78 | 2.76 | 2.98 | 4.38 | 0.69 |
Return on Equity (ROE) | 21.21% | 28.24% | 7.71% | 1.82% | 3.82% | 12.13% |
Return on Assets (ROA) | 10.63% | 14.69% | 4.01% | 1.46% | 2.63% | 4.94% |
Return on Invested Capital (ROIC) | 27.32% | 35.76% | 9.12% | 2.76% | 4.90% | 8.17% |
Return on Capital Employed (ROCE) | 19.90% | 24.30% | 7.20% | 2.70% | 3.80% | 9.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 10.57% | 14.52% | 7.42% | 1.68% | 1.24% | - |
FCF Yield | 8.22% | 14.46% | 10.73% | -2.19% | 2.80% | - |
Dividend Yield | 7.86% | 10.20% | 5.29% | 3.40% | 4.48% | - |
Payout Ratio | 82.20% | 45.01% | 83.10% | 434.67% | 103.33% | 30.16% |
Buyback Yield / Dilution | 0.93% | - | - | -28.46% | -8.99% | - |
Total Shareholder Return | 8.79% | 10.20% | 5.29% | -25.05% | -4.50% | - |